Cardlytics – $76 Million IPO

Boston – April 2, 2018 – Cooley advised Cardlytics on its $75.7 million initial public offering of 5,821,355 shares of common stock, including 421,355 shares sold pursuant to the partial exercise of the underwriters’ overallotment option. Partners Nicole Brookshire and Eric Jensen led the Cooley team advising Cardlytics.

BofA Merrill Lynch and J.P. Morgan are acting as joint book-running managers and representatives of the underwriters for the offering. Wells Fargo Securities and SunTrust Robinson Humphrey are also acting as book-runners for the offering. Raymond James and KeyBanc Capital Markets are acting as co-managers for the offering.

Cardlytics, which now trades on the Nasdaq Global Market under the symbol “CDLX,” uses purchase intelligence to make marketing more relevant and measurable. It partners with more than 2,000 financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.